索诺玛制药2025年第三季度GAAP每股收益$(0.63) 超出预期$(0.69),销售额$3.564 未达预期$4.060M

财报速递2025-02-06
索诺玛制药(NASDAQ:SNOA)报告季度每股亏损$(0.63),优于分析师一致预期的$(0.69),增长率为8.7%。这是比去年同期每股亏损$(1.60)增加了60.63%。公司报告季度销售额为$3.564,未达分析师一致预期的$4.060百万,差距为100.00%。这比去年同期的销售额$3.138百万下降了100.00%。

以上内容来自Benzinga Earnings专栏,原文如下:

Sonoma Pharmaceuticals (NASDAQ:SNOA) reported quarterly losses of $(0.63) per share which beat the analyst consensus estimate of $(0.69) by 8.7 percent. This is a 60.63 percent increase over losses of $(1.60) per share from the same period last year. The company reported quarterly sales of $3.564 which missed the analyst consensus estimate of $4.060 million by 100.00 percent. This is a 100.00 percent decrease over sales of $3.138 million the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法